A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

NCT07682506 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Vitiligo

Interventions

DRUG: MH004 1.0% Ointment
DRUG: MH004 Placebo Ointment

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd